DOGNESS INTERNATIONAL CORP-A (DOGZ)

VGG2788T1113 - Common Stock

38  +1.4 (+3.83%)

After market: 37.5 -0.5 (-1.32%)

Fundamental Rating

2

Taking everything into account, DOGZ scores 2 out of 10 in our fundamental rating. DOGZ was compared to 49 industry peers in the Textiles, Apparel & Luxury Goods industry. While DOGZ seems to be doing ok healthwise, there are quite some concerns on its profitability. DOGZ has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DOGZ has reported negative net income.
In the past year DOGZ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DOGZ reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DOGZ reported negative operating cash flow in multiple years.

1.2 Ratios

DOGZ has a worse Return On Assets (-6.10%) than 77.08% of its industry peers.
The Return On Equity of DOGZ (-7.93%) is worse than 66.67% of its industry peers.
Industry RankSector Rank
ROA -6.1%
ROE -7.93%
ROIC N/A
ROA(3y)-3.41%
ROA(5y)-4.38%
ROE(3y)-4.56%
ROE(5y)-5.58%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DOGZ's Gross Margin of 21.03% is on the low side compared to the rest of the industry. DOGZ is outperformed by 89.58% of its industry peers.
DOGZ's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DOGZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.65%
GM growth 5Y-10.17%

More info and screens

5

2. Health

2.1 Basic Checks

DOGZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DOGZ has been increased compared to 1 year ago.
The number of shares outstanding for DOGZ has been increased compared to 5 years ago.
DOGZ has a better debt/assets ratio than last year.

2.2 Solvency

DOGZ has an Altman-Z score of 12.69. This indicates that DOGZ is financially healthy and has little risk of bankruptcy at the moment.
DOGZ's Altman-Z score of 12.69 is amongst the best of the industry. DOGZ outperforms 93.75% of its industry peers.
DOGZ has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DOGZ (0.06) is better than 72.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 12.69
ROIC/WACCN/A
WACC7.5%

2.3 Liquidity

DOGZ has a Current Ratio of 1.92. This is a normal value and indicates that DOGZ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.92, DOGZ is in line with its industry, outperforming 43.75% of the companies in the same industry.
A Quick Ratio of 1.56 indicates that DOGZ should not have too much problems paying its short term obligations.
DOGZ has a better Quick ratio (1.56) than 72.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.56

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.65% over the past year.
Looking at the last year, DOGZ shows a very negative growth in Revenue. The Revenue has decreased by -15.59% in the last year.
The Revenue for DOGZ have been decreasing by -10.75% on average. This is quite bad
EPS 1Y (TTM)84.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.98%
Revenue 1Y (TTM)-15.59%
Revenue growth 3Y-15.17%
Revenue growth 5Y-10.75%
Sales Q2Q%13.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DOGZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DOGZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOGNESS INTERNATIONAL CORP-A

NASDAQ:DOGZ (1/6/2025, 8:00:01 PM)

After market: 37.5 -0.5 (-1.32%)

38

+1.4 (+3.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)N/A N/A
Inst Owners0.45%
Inst Owner Change0%
Ins Owners54.62%
Ins Owner ChangeN/A
Market Cap483.74M
Analysts0
Price TargetN/A
Short Float %19.41%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.58
P/FCF N/A
P/OCF 594.4
P/B 6.33
P/tB 6.48
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.06
OCFY0.17%
SpS1.17
BVpS6
TBVpS5.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.1%
ROE -7.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.03%
FCFM N/A
ROA(3y)-3.41%
ROA(5y)-4.38%
ROE(3y)-4.56%
ROE(5y)-5.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.65%
GM growth 5Y-10.17%
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 127.17%
Cap/Sales 23.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.56
Altman-Z 12.69
F-Score5
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)204.66%
Cap/Depr(5y)299.26%
Cap/Sales(3y)29.57%
Cap/Sales(5y)39.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.59%
Revenue growth 3Y-15.17%
Revenue growth 5Y-10.75%
Sales Q2Q%13.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.14%
OCF growth 3Y-39.91%
OCF growth 5YN/A